Search research articles
Contact Us
Filters
Showing results (21-30 of 144) with videos related to
Page
of 15
Sort By:
Journal of Managed Care Pharmacy : JMCP
|
September 20, 2006
What are incretins, and how will they influence the management of type 2 diabetes?
Lawrence Blonde, Julio Rosenstock, Curtis Triplitt
Advances in Therapy
|
June 28, 2018
Correction to: Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations
Lawrence Blonde, Susana Dipp, Daniel Cadena
The American Journal of Managed Care
|
November 1, 2002
Thiazolidinediones in the treatment of managed care patients with type 2 diabetes
Ram Pathak, Azar Afaq, Lawrence Blonde
Advances in Therapy
|
January 25, 2012
Fixed-dose combinations for treatment of type 2 diabetes mellitus
Lawrence Blonde, Zinnia T San Juan
Advances in Therapy
|
May 20, 2018
Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations
Lawrence Blonde, Susana Dipp, Daniel Cadena
The Journal of Family Practice
|
September 30, 2022
Safe and Appropriate Use of GLP-1 RAs in Treating Adult Patients With Type 2 Diabetes and Macrovascular Disease
James LaSalle, Lucia M Novak, Lawrence Blonde
Diabetes Care
|
March 29, 2003
Thalidomide-associated hyperglycemia and diabetes: case report and review of literature
Ram D Pathak, Kandaswamy Jayaraj, Lawrence Blonde
The Journal of Family Practice
|
June 21, 2019
Real-world evidence in diabetes: relevance to clinical practice
Lawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Reviews in Endocrine & Metabolic Disorders
|
July 15, 2022
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Vanita R Aroda, Lawrence Blonde, Richard E Pratley
Ochsner Journal
|
May 24, 2011
Effective glycemic management in hospitalized patients: a multidisciplinary approach
Margaret Bolton, Anita Richard, Lawrence Blonde, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 144) with videos related to
Sort By:
Page
of 15
Journal of Managed Care Pharmacy : JMCP
|
September 20, 2006
What are incretins, and how will they influence the management of type 2 diabetes?
Lawrence Blonde, Julio Rosenstock, Curtis Triplitt
Advances in Therapy
|
June 28, 2018
Correction to: Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations
Lawrence Blonde, Susana Dipp, Daniel Cadena
The American Journal of Managed Care
|
November 1, 2002
Thiazolidinediones in the treatment of managed care patients with type 2 diabetes
Ram Pathak, Azar Afaq, Lawrence Blonde
Advances in Therapy
|
January 25, 2012
Fixed-dose combinations for treatment of type 2 diabetes mellitus
Lawrence Blonde, Zinnia T San Juan
Advances in Therapy
|
May 20, 2018
Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations
Lawrence Blonde, Susana Dipp, Daniel Cadena
The Journal of Family Practice
|
September 30, 2022
Safe and Appropriate Use of GLP-1 RAs in Treating Adult Patients With Type 2 Diabetes and Macrovascular Disease
James LaSalle, Lucia M Novak, Lawrence Blonde
Diabetes Care
|
March 29, 2003
Thalidomide-associated hyperglycemia and diabetes: case report and review of literature
Ram D Pathak, Kandaswamy Jayaraj, Lawrence Blonde
The Journal of Family Practice
|
June 21, 2019
Real-world evidence in diabetes: relevance to clinical practice
Lawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Reviews in Endocrine & Metabolic Disorders
|
July 15, 2022
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
Vanita R Aroda, Lawrence Blonde, Richard E Pratley
Ochsner Journal
|
May 24, 2011
Effective glycemic management in hospitalized patients: a multidisciplinary approach
Margaret Bolton, Anita Richard, Lawrence Blonde, et al.
Page
of 15